chrisvoncsefalvay/vaers-outcomes huggingface dataset:
muscle soreness at injection site (2 days), comparable to tetanus (proactively iced area, went to vaccination site well hydrated, remained hydrated through the day, used Max Freeze and Arnica proactively joint pain in right thumb for appx 2 hours on day of vaccine, which cleared/migrated to first two fingers of right hand for appx 1 hour before clearing completely chills beginning appx 7:30 pm 3/25/21, lasting 1 hour fever beginning appx 8:30 pm 3/25/21, 101+, lasting until appx 8:00 am Friday, then dropping gradually to 99 by 1:00 pm Friday (at which time I took an ibuprofen) fatigue beginning appx 9:00 pm 3/25/21, persisting through Friday and decreasing through the day Saturday (I went to sleep at 9:00 Thursday night (3/25) slept fitfully, waking every 1.5-2 hours through Thursday night and until 10:00 am Friday, then went back to sleep by 1:00 pm Friday through appx 4:30, took several 30 minute naps that evening and went to sleep for the night by 10:00 pm, slept until 8:30 Saturday morning and took several naps through the day on Saturday totaling another 4-5 hours of sleep.) Frequent, urgent need to urinate (beginning around 10:30 Thursday night (3/25) through 8:00 am Friday morning) - very unusual, low production for urgency. mild headache Friday, persisting until appx 1:30 pm (when I took an ibuprofen) intense sinus pressure over left eye Sunday 3/27, beginning at 9:00 pm and persisting until I took an ibuprofen at appx 11:30 (I had tried to sleep it off but it was interfering with sleep) and continuing in very mild form through current time of 9:00 am Monday 3/29
another tender red mark, similar to injection site, popped up on the opposite arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Oct2021 09:30 (Batch/Lot number: unknown) at the age of 59 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), administered in arm right, administration date 18Oct2021 (Batch/Lot number: unknown). Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN; MONTELUCAST; BENADRYL; TYLENOL ARTHRITIS. Vaccination history included: Bnt162b2 (Dose Number: 2, Location of injection: Arm Left, Vaccine Administration Time: 09:30 AM), administration date: 12Apr2021, when the patient was 59 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Location of injection: Arm Left, Vaccine Administration Time: 09:30 AM), administration date: 15Mar2021, when the patient was 59 years old, for COVID-19 Immunization. The following information was reported: ERYTHEMA (non-serious) with onset 20Oct2021 18:00, outcome "recovering", described as "another tender red mark, similar to injection site, popped up on the opposite arm". Therapeutic measures were not taken as a result of erythema.  Additional Information: The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. About 2 days after the vaccine, there was another tender red mark, similar to injection site, popped up on the opposite arm. No covid prior vaccination. Covid was not tested post vaccination.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The patient was given the Pfizer BioNTech COVID vaccine - incorrect diluent type was used  (sterile water for injection)  instead of preservative-free normal saline.  MD was notified, Patient had no symptoms and monitored the patient.
Arm became severely sore after 90 minutes. Could not lift arm.  Shoulder area remains painful  with movement with pain radiating to neck/head at times.  Shoulder and upper arm has limited range of motion.  A "clicking" sensation occurs when moving in a circular motion.
08:40PM tingling sensation in his left index 09:10PM tingling sensation persist but in a milder way.  Pt left the facility 01/17/2021 08:30AM Pt states tingling sensation "stopped by the time I woke up Friday 01/15/2021.  Otherwise I felt completely fine."
Got shingles exactly after 4 weeks of shingles vaccine administered was prescribed VALTREX 1 gram for 7 days.
swelling on his right side; enlarged lymph node; This spontaneous case was reported by an other health care professional and describes the occurrence of SWELLING (swelling on his right side) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced SWELLING (swelling on his right side). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SWELLING (swelling on his right side) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.   This case was linked to MOD-2021-044562 (Patient Link).
got the Shot But I still got the Shingles/ suspected vaccination failure; got the Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated that he/she got the shingles shot but still got the Shingles and his/her physician said it would had been a lot worse, if had he/she not took the shot, so make sure you get the shot. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
5 injections given. Rt leg has dime size swollen, red, area at injection site L leg swollen, hot to touch, involving most of anterior lateral thigh. Pt complains when area touched.
I received my flu vaccine at my Pulmonologists. When I felt the needle pierce my skin I immediately thought, "Is this a new location for the flu shot?" as it was not placed in the head of my Deltoid but off to the side of the Deltoid in my Rt arm.  By the end of the day I noted the usual ache. The next morning when I woke, I felt the ache but as I moved my Rt arm, the muscles felt angry and sharp like they did in 2016 when I broke my shoulder.  It was painful.  I took Ibuprofen which somedays it took the edge off. I continued to try and function but became more and more limited by the sharp pain. I think some of it was because I didn't recognize that part of what I was feeling was muscle spasms. I did my best to ride my bike until the weather cooled down and noted that my right arm seemed more crooked as I looked down at the handle bars.  I was placed on a steroid for a rash, that didn't touch the inflamation I felt in my shoulder. I went to PT. I finally wrote notes to my PCP and Pulmonologist.  THen Sunday My biceps Tendon popped, I had to go to the ER, XR,MRI later in the week.  Waiting to discover the problem. Dr said that vaccine medicine can irritate joints and tissues.
Patient presented with rash on left arm that extended fro injection site to shoulder and elbow. Patient stated she had trouble breathing and walking after she received vaccine. Patient presented to pharmacy two days after vaccination was received to tell pharmacist about her experience. Patient had waited at pharmacy for about 10 minutes after she received vaccination. Patient was advised to contact her physician.
Very bad headache, stabbing pain in neck, could not move head side to side or up and down.
Information has been received from a LPN concerning a 21 month old pediatric pt who on 9/28/01, at 11:00, was vaccinated SC, in her right thigh, with varicella virus vaccine live (lot 638491/1901K). At that time, the pt's temperature was 97.5F. On follow-up, it was reported that on 9/28/01, at 15:00, 4 hours, post vax, the pt developed a fever and excessive vomiting. The pt was taken to her physician's office for medical attention for her symptoms. At 15:43, the pt's temperature was 102.7F. The pt developed grunting (respiratory distress( because of her rapid rise in temperature. She was placed on a pulse oximeter which revealed an oxygen saturation of 87%. The pt was placed on oxygen therapy and sent to the ER via ambulance. After 1 hour of oxygen therapy, the pt recovered. Her oxygen saturation via pulse oximeter was 99%. Upon internal review, respiratory distress was considered to be an "Other Important Medical Event". In a few hours, after her arrival in the ER, the pt was sent home with a low-grade fever (99.0F to 100F) which lasted 2 days. Subsequently, the pt recovered from her symptoms. No further information was reported. Further follow up info was received from a physician. The child was evaluated on 10/26/01 for thrombocytosis. At the time of evaluation, he did not have any clinical symptoms. His physical exam and lab studies were within normal limits (HGS 12.7, WBC 7,700 and platelet count 359,000). It was documented that he was first noted to have an elevated platelet count "earlier this year," that elevated between 700 to 100,00 at times of viral infections or infectious processes and resolved when the infections subsided. He was diagnosed with reactive thrombocytosis. The physician indicated that the child would be followed on an "as needed" basis. Additional follow up inof revealed that the child had Pre-existing asthma. He was seen on 11/6/01 and it was reported that he seemed to have "done well with regard to asthma symptoms over the summer." It was reported that the physician thought the pt needed to use his nebulizer once. It was not known what the trigger was in that instance. On the whole, the child had not needed to use the nebulizer. It was noted that generally, he has more trouble during the child season. At the time of this evaluation, the child's chest was clear. The physician noted that varicella virus vaccine live "does not contain any egg proteins" and that if the child reacted to the vaccine, it might be attributed to another component, "possibly the gelatin." He further noted that he was not quite sure to what the child reacted. In addition, it was noted that the child had tolerated vaccination with MMR II without problems. No further info is available.
ODOR. I am constantly smelling smoke. As if I am holding a cigarette ashtray against my nose when taking deep breath; This is a spontaneous report from a contactable nurse (patient). A 50-year-old male patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: EH9899; expiration date: not known), via an unspecified route of administration on left arm on 16Dec2020 13:30 at single dose for covid-19 immunization, administered in hospital. The patient's medical history and concomitant medications were not reported. The patient previously took aspirin and experienced allergies. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 23Dec2020 13:00, the patient experienced "ODOR". He was constantly smelling smoke. As if he was holding a cigarette ashtray against his nose when taking deep breath. This started a week after the first injection. The reported event is non-serious. No treatment was received for the event. The outcome of the event was not recovered.
Atrial fibrillation; This is a spontaneous report received from contactable reporter(s) (Other HCP). Other Case identifier(s): MOD-2023-718093 (Moderna).  An adult male patient received BNT162b2 (BNT162B2), on 03Mar2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, her husband has received 2 doses the Pfizer COVID 19 vaccine for the primary series), for COVID-19 IMMUNIZATION; Bnt162b2 (DOSE 2, SINGLE, her husband has received 2 doses the Pfizer COVID 19 vaccine for the primary series), for COVID-19 IMMUNIZATION. The following information was reported: ATRIAL FIBRILLATION (medically significant) with onset 2022, outcome "unknown". The event "atrial fibrillation" required physician office visit. The patient underwent the following laboratory tests and procedures: Electrocardiogram: his heart is still not right per a cardiogram. Therapeutic measures were taken as a result of atrial fibrillation. Clinical course: Caller states that she is calling on behalf of her husband who is the patient. She says that her husband has received 2 doses the Pfizer COVID 19 vaccine for the primary series as well as one booster dose of Pfizer. His last booster was on 03Mar2022. She mentions that approximately 8 months after received the Pfizer booster, his husband developed atrial fibrillation. Caller states that she does not think there is any correlation of the a-fib with the Pfizer vaccine. They met with the cardiologist today who is advocating receiving the Moderna COVID-19 bivalent booster dose for the patient at this time as his heart is still not right per a cardiogram that was done today. The patient is having a hard time breathing all the way in deeply due to the atrial fibrillation. Patient has been put on Eliquis and Metoprolol for the a-fib.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300145124 same paitent, different drug/event.;
Evening of 5/7: Severe headache, fever, violent shivering, vomited once. Day of 5/8: 1st spots (red itchy) appeared on the forehead, lingering headache. Day of 5/9-5/11: Slight headache, body covered in red, itchy spots all over.
I have experienced Headache; chills; felt weak the first day; This is a spontaneous report received from a contactable other health Care Professional (patient herself). A 45-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via unspecified route of administration, in right arm on 03Feb2021 16:00 at single dose for COVID-19 immunization. Medical history included Allergies: Penicillin and Allergies: Sulfa. The patient concomitant medications were not reported. Patient previously took first dose BNT162B2 on 13Jan2021 16:00 for COVID-19 immunization. On 04Feb2021 06:00, the patient experienced chills, first day felt weak, the second day felt better and Third- and fourth-days experienced headache. Treatment received was reported as no. The event considered non serious. The outcome of the events was recovering.  Batch/lot number has been requested.
positive test result for Covid 19; positive test result for Covid 19; This is a spontaneous report from a contactable consumer. A 71-year-old male patient (father) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number was not reported), dose 2 via intramuscular route in right arm on 05Mar2021 at 09:00 as single dose for COVID-19 immunisation. The patient's medical history included hypertension from an unknown date. There were no concomitant medications reported. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number was not reported) dose 1 via intramuscular route in right arm on 15Feb2021 at 10:00 as single dose for COVID-19 immunisation. On 11Sep2021 at 07:00, approximately 190 days after the second dose, the patient had positive test result for COVID-19, first dose was received on 15Feb2021/ second dose was received on 05Mar2021, flu like symptoms, slight fever, feelings of light headedness, cough and runny nose. The adverse events resulted in physician's office visit. The patient underwent sars-cov-2 test (nasal swab) which was positive on 13Sep2021. The patient was not tested positive for covid-19 prior to vaccination. The outcome of all the events was not recovered.  The lot number for the vaccine was not provided and will be requested during follow-up.
Numbness - Left side of face & lip (comes & goes) now on right side.  Runny nose.  Chills.  Cannot regulate body temperature.
While waiting for bus one hour & 45 minutes after shot- chills, fatigue- went home took Tylenol, slept 2 hours- felt better, that evening (Mon) congestion, cough. 11/19/09 shortness of breath, cough. Told to call doctor clinic. 12/8-12/9/2009 OB records ov's 11/2009, patient with c/o's productive cough, SOB post vaccine, started on Tamiflu with no improvement, seen 11/24/2009 and started on ABX.
4:10PM SYNCOPE -EASED TO FLOOR BECAME RESPONSIVE. MOVED TO COT PER WHEEL CHAIR. A/O, PINK, W/D, RESP WITH EASE. NO PAIN, NO SOB. FAMILY X 3 AT SIDE. 4:20PM 'FEELS BETTER'. CRACKERS AND WATER GIVEN. 4:31TO EXIT PER WHEEL CHAIR, MOM TO DRIVE PT HOME. NO ACUTE DISTRESS NOTED. 4-2-21 12N TC:  'FEELS FINE TODAY'.
A report was received from a health professional on 10/25/02, concerning as unknown number of vaccinees of unknown demography who experienced injection site reactions after receiving the Fluvirin vaccine on 10/11/02. On 10/11/02, an unspecified number of vaccines experienced redness, swelling and soreness at the injection site. There was insufficient information to determine the reporter's causality assessment.
4 inch diameter raised, red, itchy, painful region on left upper arm near vaccination site, developed on 9th day after injection (first dose).
She cannot move her left arm; Patient was crying as she was in so much pain; 4 hours later, she had a terrible pain in left shoulder.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (She cannot move her left arm), PAIN (Patient was crying as she was in so much pain) and ARTHRALGIA (4 hours later, she had a terrible pain in left shoulder.) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (She cannot move her left arm), PAIN (Patient was crying as she was in so much pain) and ARTHRALGIA (4 hours later, she had a terrible pain in left shoulder.). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (She cannot move her left arm), PAIN (Patient was crying as she was in so much pain) and ARTHRALGIA (4 hours later, she had a terrible pain in left shoulder.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment medication included Ice compression.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: TCR received: patient declined further follow up.
Initial report received from a healthcare professional on 10 April 2013. A female patient, whose age, medical history and concomitant medications were not reported, had received an intramuscular dose of ADACEL vaccine (lot number: U4612AA, site of administration was not reported) on an unspecified date. The patient was pregnant. The patient's last menstrual period date was 10 August 2012 and the expected date of delivery is 15 May 2013. At the time of this report, the patient did not experienced any adverse event. List of documents held by the sender: None.
Moderna Spikevax, administered in left arm at Pharmacy  12 days later, extreme skin irritation with minimal provocation Itching, redness, swelling Flare-ups came and went  Found "Delayed Onset of Symptomatic Dermatographism following COVID-19 mRNA Booster?  That seems possibly related, and no obvious other variable has been identified (such as new foods, detergents, etc.). But, of course, could be completely unrelated to the vaccine.  No reactions to any other vaccine or booster.   Took antihistamines, which seem to have cooled the problem. Four days on, skin redness still occurs when skin is irrita ted, but it is not itching or painful.
patient verbalized and on consent form to no prior issues with vaccines, and no history of problems when receiving, or allergies before vaccination. advised patient to wait in designated waiting area. As patient was sitting in chair, she immediately lost consciousness, and her mom was able to hold her up on the chair while i ran over within seconds. i gently shook the patients shoulders and put her feet up on a chair, and she regained consciousness. gave her water and crackers, and hard candy. sat with her for 5 minutes and told her to wait a full 30 before leaving. after the 5 minutes she was feeling normal. checked with me before leaving. patient then stated that this had happened before. i told the mother to advise us of this in the future before giving any vaccines.
Horrible body odor; Extreme night sweats; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (RA).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: SKIN ODOUR ABNORMAL (non-serious), outcome "unknown", described as "Horrible body odor"; NIGHT SWEATS (non-serious), outcome "unknown", described as "Extreme night sweats".  Additional information: The reporter wanted to know whether we had any information on how to get rid of the horrible body odor as a side effect of the booster shots. The reporter so far known 12 women with this issue. They also had extreme night sweats. The reporter had read 12 different articles regarding this side effect. A lot of people were having this trouble and this was becoming a major problem.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300006689 Same reporter/drug/event, different patient;
Very sore arm after receiving Pneumovax; difficulty lifting arm which subsided by about 36 hrs.
Received DTaP # 5 in RA on 06/15 and within hours developed redness, swelling at site